Molecular markers in breast cancer: Can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors?

C-erbb-2 oncoprotein expression versus i

C-erbb-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer

✍ Masakuni Noguchi; Naohiro Koyasaki; Nagayoshi Ohta; Hirohisa Kitagawa; Mitsuharu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

The relationship was assessed between c-erbB-2 oncoprotein expression and other prognostic factors in breast cancer, such as axillary and internal mammary node metastases. The value of these indicators was analyzed in estimating prognosis, especially in patients with axillary node-positive breast ca